and 11:15 a.m.
Mr. Hoppenbrouwers' presentation will focus on Catalent's expertise in providing solutions for tech transfer projects when working with complex products and will address the following common challenges:
• temperature instability,
• formulation development and manufacturing issues, and
• visual inspection, packaging, and frozen chain supply distribution for complex biopharmaceutical products.
Throughout this case study, Mr. Hoppenbrouwers will demonstrate the ability to identify novel approaches and manufacturing best practices which allows Catalent to provide reliable solutions for the most challenging tech transfer projects.
Mr. Hoppenbrouwers is Catalent's Director of NewProduct Development for Sterile Technologies. He has a Masters Degree in Chemical Engineering and is licensed in pharmaceutical engineering. He has extensive experience in pharmaceutical research and development and expertise with sterile facility design, project management, and technical sales.
To arrange a follow-up interview withEdwin Hoppenbrouwers, please contact Patricia McGee.
For more information or to register for the conference, visit here.
To learn more about our sterile technologies click here, to learn more about Catalent click here,
Mr. Hoppenbrouwers' presentation will focus on Catalent's expertise in providing solutions for tech transfer projects when working with complex products and will address the following common challenges:
• temperature instability,
• formulation development and manufacturing issues, and
• visual inspection, packaging, and frozen chain supply distribution for complex biopharmaceutical products.
Throughout this case study, Mr. Hoppenbrouwers will demonstrate the ability to identify novel approaches and manufacturing best practices which allows Catalent to provide reliable solutions for the most challenging tech transfer projects.
Mr. Hoppenbrouwers is Catalent's Director of NewProduct Development for Sterile Technologies. He has a Masters Degree in Chemical Engineering and is licensed in pharmaceutical engineering. He has extensive experience in pharmaceutical research and development and expertise with sterile facility design, project management, and technical sales.
To arrange a follow-up interview withEdwin Hoppenbrouwers, please contact Patricia McGee.
For more information or to register for the conference, visit here.
To learn more about our sterile technologies click here, to learn more about Catalent click here,
Companies in this press-release
